Compounds > etoposide

Page last updated: 2024-08-23

etoposide and pentoxifylline

etoposide has been researched along with pentoxifylline in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (28.57)	18.2507
2000's	6 (42.86)	29.6817
2010's	4 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dezube, B; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA	1
Akiba, Y; Fujikane, T; Fujiuchi, S; Ishida, S; Matsumoto, H; Nakano, H; Ohosaki, Y; Onodera, S; Osanai, S; Tsuji, T	1
Duba, D; Fan, S; Fornace, AJ; Kohn, KW; O'Connor, PM; Rivet, DJ; Smith, ML; Zhan, Q	1
Kabisch, H; Kalhs, P; Krüger, W; Lechner, K; Peters, S; Stockschläder, M; Zander, A; Zeller, W	1
de Vries, P; Singer, JW	1
Gude, RP; Nagarsenker, MS; Rao, SG; Sant, VP	1

Reviews

1 review(s) available for etoposide and pentoxifylline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

13 other study(ies) available for etoposide and pentoxifylline

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo. International journal of cancer, 1991, Jun-19, Volume: 48, Issue:4 Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Fibrosarcoma; Hematopoietic Stem Cells; Indazoles; Male; Melphalan; Mice; Mice, Inbred C3H; Pentoxifylline; Sarcoma, Experimental	1991
[Combination effect of pentoxifylline and etoposide on a human lung cancer cell line]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Etoposide; Humans; Lung Neoplasms; Pentoxifylline; Tumor Cells, Cultured; Tumor Stem Cell Assay	1991
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer research, 1995, Apr-15, Volume: 55, Issue:8 Topics: Apoptosis; Breast Neoplasms; Cell Line; Cell Survival; Cisplatin; Clone Cells; Doxorubicin; Etoposide; G1 Phase; Gamma Rays; Genes, p53; Genes, Viral; Humans; Methyl Methanesulfonate; Oncogenes; Papillomaviridae; Pentoxifylline; Transfection; Tumor Cells, Cultured	1995
Intravenous pentoxifylline failed to prevent transplant-related toxicities in allogeneic bone marrow transplant recipients. Bone marrow transplantation, 1993, Volume: 12, Issue:4 Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Child; Cyclophosphamide; Etoposide; Gastrointestinal Diseases; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Incidence; Infusions, Intravenous; Kidney Diseases; Middle Aged; Pentoxifylline; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha; Whole-Body Irradiation	1993
Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents. Experimental hematology, 2000, Volume: 28, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antineoplastic Agents; Bone Marrow Cells; Cell Division; Chemokine CCL4; Cisplatin; Colony-Forming Units Assay; Culture Media, Conditioned; Cytarabine; Etoposide; Female; Growth Inhibitors; Hematopoietic Stem Cells; Macrophage Inflammatory Proteins; Melphalan; Mice; Mice, Inbred BALB C; Pentoxifylline; Spleen; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2000
Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Etoposide; Female; Liposomes; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Pentoxifylline	2003